February 20th, 2012 - Volume 26 - Issue 4
pp: F1-F12,403-528

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

Van Gulck, Ellen; Vlieghe, Erika; Vekemans, Marc; More

AIDS. 26(4):F1-F12, February 20th, 2012.

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents

Königs, Christoph; Feiterna-Sperling, Cornelia; Esposito, Susanna; More

AIDS. 26(4):447-455, February 20th, 2012.

Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients

Wyen, Christoph; Jensen, Björn; Hentrich, Marcus; More

AIDS. 26(4):457-464, February 20th, 2012.

Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort

van Lelyveld, Steven F.L.; Gras, Luuk; Kesselring, Anouk; More

AIDS. 26(4):465-474, February 20th, 2012.

Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy

Curran, Adrian; Martinez, Esteban; Saumoy, Maria; More

AIDS. 26(4):475-481, February 20th, 2012.

Hormonal contraception and the risk of HIV acquisition among women in South Africa

Morrison, Charles S.; Skoler-Karpoff, Stephanie; Kwok, Cynthia; More

AIDS. 26(4):497-504, February 20th, 2012.

Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships

Ngure, Kenneth; Heffron, Renee; Mugo, Nelly R.; More

AIDS. 26(4):513-518, February 20th, 2012.

Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment

Di Lucca-Christment, Julie; Jacobelli, Simon; Gressier, Ludivien; More

AIDS. 26(4):523-526, February 20th, 2012.